Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3006 |
|
| Actual shortage: | 230 (8%) | |
| Anticipated shortage: | 20 (1%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2747 (91%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
27 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-LITHIUM CARBONATE | 150MG | CAPSULE | Actual shortage | 2024-04-19 | 2024-04-19 | 225802 |
| APO-GLICLAZIDE | 80MG | TABLET | Actual shortage | 2024-04-19 | 2024-04-19 | 225799 |
| APO-DOXYCYCLINE MR | 40MG | CAPSULE (IMMEDIATE AND DELAYED RELEASE) | Actual shortage | 2024-04-19 | 2024-04-19 | 225796 |
| APO-GLICLAZIDE MR | 30MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-04-19 | 2024-04-19 | 225793 |
| APO-TADALAFIL | 10MG | TABLET | Actual shortage | 2024-04-19 | 2024-04-19 | 225790 |
| APO-TADALAFIL PAH | 20MG | TABLET | Actual shortage | 2024-04-19 | 2024-04-19 | 225785 |
| APO-WARFARIN | 1MG | TABLET | Actual shortage | 2024-04-19 | 2024-04-19 | 225782 |
| APO-ALFUZOSIN | 10MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-04-19 | 2024-04-19 | 225779 |
| APO-DASATINIB | 70MG | TABLET | Actual shortage | 2024-04-19 | 2024-04-19 | 225776 |
| APO-TADALAFIL | 2.5MG | TABLET | Actual shortage | 2024-04-19 | 2024-04-19 | 225773 |
| APO-METFORMIN ER | 500MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-04-19 | 2024-04-19 | 225770 |
| APO-TRIMEBUTINE | 100MG | TABLET | Actual shortage | 2024-04-19 | 2024-04-19 | 225767 |
| APO-VARENICLINE | 1MG | TABLET | Actual shortage | 2024-04-19 | 2024-04-19 | 225764 |
| APO-LANSOPRAZOLE | 30MG | CAPSULE (DELAYED RELEASE) | Actual shortage | 2024-04-19 | 2024-04-19 | 225761 |
| APO-ANASTROZOLE | 1MG | TABLET | Anticipated shortage | 2024-04-12 | 2024-04-12 | 225101 |
| APO-TICAGRELOR | 90MG | TABLET | Actual shortage | 2024-04-12 | 2024-04-12 | 225026 |
| APO-BISOPROLOL | 5MG | TABLET | Actual shortage | 2024-04-12 | 2024-04-12 | 225023 |
| APO-CEPHALEX | 500MG | TABLET | Actual shortage | 2024-04-12 | 2024-04-12 | 225020 |
| APO-VERAP TABLET 120MG | 120MG | TABLET | Actual shortage | 2024-04-12 | 2024-04-12 | 225017 |
| APO-LORAZEPAM | 0.5MG | TABLET | Actual shortage | 2024-04-12 | 2024-04-19 | 225014 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-09-07 | 2018-11-09 | 60282 |
| APO-ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-09-07 | 2019-02-13 | 60279 |
| APO-ATORVASTATIN | 10MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60276 |
| APO-ATOMOXETINE | 60MG | CAPSULE | Discontinued | 2018-09-07 | 2018-09-15 | 60273 |
| APO-ATENOL TAB 50MG | 50MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60267 |
| APO-ATENOL TAB 100MG | 100MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60261 |
| APO-ASA LD | 81MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60252 |
| APO-AMOXI SUGAR FREE | 125MG | POWDER FOR SUSPENSION | Discontinued | 2018-09-07 | 2018-09-15 | 60249 |
| APO-AMOXI SUGAR FREE | 125MG | POWDER FOR SUSPENSION | Discontinued | 2018-09-07 | 2018-09-15 | 60246 |
| APO-AMOXI CLAV 125MG/31.25MG PER 5ML | Discontinued | 2018-09-07 | 2018-09-15 | 60241 | ||
| APO-AMOXI | 500MG | CAPSULE | Discontinued | 2018-09-07 | 2018-11-09 | 60174 |
| APO-AMOXI | 250MG | CAPSULE | Discontinued | 2018-09-07 | 2019-02-13 | 60171 |
| APO-ALENDRONATE | 10MG | TABLET | To be discontinued | 2018-09-07 | 2019-12-20 | 60163 |
| APO-ACETAMINOPHEN CAPLETS EXTRA STRENGTH | 500MG | TABLET | Discontinued | 2018-09-07 | 2018-09-08 | 60157 |
| APO-CETIRIZINE | Discontinued | 2018-05-31 | 2018-05-31 | 50998 | ||
| APO-CEFPROZIL | 500MG | TABLET | Discontinued | 2018-04-04 | 2018-10-05 | 44945 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41047 |
| APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41020 |
| APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-05-03 | 41011 |
| APO-GAIN LIQ 20MG/ML | 20MG | SOLUTION | Discontinued | 2018-02-26 | 2018-02-26 | 40997 |